SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TKB who wrote (33)1/28/1999 12:31:00 AM
From: Coop  Read Replies (2) of 105
 
According to the IR firm that the company has hired (here in Tulsa), there will be a TV show featuring the syringe broadcast in LA (market of over 15 million) sometime in the next week. The highlight will be an actual demonstration of the final product (ready for shipment to the FDA), that testing was completed on last Friday.

Also, February 4 there will be a meeting with a major medical company (they wouldn't say the name) about the purchase of MXON. Maxxon has an exit strategy of being acquired by a major company and this Feb. 4th meeting is the first with other companies waiting in the wings.

I believe that the syringes were also said to be accompanied by an application for FDA approval. Call the company and check, they are full of info.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News